Revvity Inc
(NYSE:RVTY)
$
116.14
-0.09 (-0.08%)
Market Cap: 14.13 Bil
Enterprise Value: 16.22 Bil
PE Ratio: 56.19
PB Ratio: 1.79
GF Score: 81/100 PerkinElmer Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 13, 2022 / 02:50PM GMT
Release Date Price:
$132.71
(-6.79%)
Thomas Peterson
Robert W. Baird & Co. Incorporated, Research Division - Research Analyst
Thanks, everyone. Welcome. Thank you for joining. I'm Tom Peterson, I'm an associate here on our Life Sciences and Tools list here at Baird. We're excited to have PerkinElmer presenting today. And representing the company, we have CEO, Prahlad Singh. Prahlad, welcome.
Prahlad R. Singh
PerkinElmer, Inc. - CEO, President & Director
Thank you, Tom.
Thomas Peterson
Robert W. Baird & Co. Incorporated, Research Division - Research Analyst
So as far as the agenda, I think Prahlad, you're going to give an overview here with a couple of slides, and then we'll hop into Q&A.
Prahlad R. Singh
PerkinElmer, Inc. - CEO, President & Director
Yes. I mean rather than those slides, I'll -- I'm much more comfortable just talking. So here it goes. We are really at an exciting stage in the life cycle of our company. Our recent announcement of the divestment of the Applied and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot